MoonLake Immunotherapeutics - COMMON STOCK (MLTX)

CUSIP: 61559X104

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+1,243,105
Put/Call ratio
76%
SEC-reported price per share
$54.15
Number of holders
114
Value change
+$68,390,992
Number of buys
65
Open additional details 1 more signal available
Number of sells
44
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
80,766,491

Security key

61559X104

Report period

Q4 2024

Institutions

114

Top holders

10

Ownership snapshot

Top reported holders of MLTX - MoonLake Immunotherapeutics - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F 3/4/5 Highest disclosed value: $1,096,699,739 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $1.1B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.
Disclosed position value Top 5
BVF INC/IL $1.1B
Cormorant Asset Management, LP $428.28M
Helix Holdings LLC $192.57M
PRICE T ROWE ASSOCIATES INC /MD/ $150.26M
Avoro Capital Advisors LLC $139.67M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BVF INC/IL
13F
Company
13F
—
denominator unverified
$1,096,699,739
21,751,284 shares
— 30 Sep 2024
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$428,275,093
8,494,151 shares
— 30 Sep 2024
Helix Holdings LLC
3/4/5
Former 10% Holder
—
denominator unverified
$192,569,820
3,215,000 shares
— 05 Apr 2022
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$150,265,000
2,980,249 shares
— 30 Sep 2024
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$139,668,442
2,770,100 shares
— 30 Sep 2024
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$117,124,198
2,322,971 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
114
Shares
63,244,825
Rows available
114
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
108
Q4 2024 holders
114
Holder diff
6
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .